Connect with others who understand.

Sign up Log in
Resources
About MyPsoriasisTeam
Powered By
See answer
PSORIASIS
NEWS

Otezla Now Approved for All Severity Levels of Psoriasis

Medically reviewed by Ariel D. Teitel, M.D., M.B.A.
Written by Maureen McNulty
Posted on January 12, 2022
(Adobe Stock)

  • The U.S. Food and Drug Administration (FDA) recently approved a new use for Otezla (apremilast).
  • Apremilast can now be used to treat mild to moderate plaque psoriasis, making it the only drug currently approved for all severity levels of psoriasis.
  • A clinical trial found that apremilast improved psoriasis signs and symptoms in people with milder disease cases.

The FDA recently approved Otezla as a treatment for adults with mild to moderate plaque psoriasis who are eligible to receive phototherapy (light treatments) or systemic therapy (medications that travel throughout the bloodstream). The decision was announced on Dec. 20.

Otezla was originally approved in March 2014 to treat psoriatic arthritis. A few months later, the FDA approved the drug as a treatment option for people with moderate to severe plaque psoriasis.

This expanded approval is good news for people with milder cases of psoriasis, according to Dr. David M. Reese, executive vice president of research and development at Amgen — the company that makes Otezla.

“A substantial unmet need remains for mild to moderate plaque psoriasis patients for whom topical therapies may not be sufficient, especially for those with difficult-to-treat areas, like the scalp,” said Dr. Reese in a recent press release. “With this expanded indication for Otezla, patients across all levels of disease severity now have an oral, systemic option that has already been used by more than 650,000 people worldwide.”

Is Otezla Effective?

Otezla’s new approval came after Amgen reported positive results from its phase 3 ADVANCE trial, which measured safety and effectiveness of the drug in people with mild or moderate psoriasis. There have been a few key findings from this trial so far:

  • People who took apremilast were five times more likely to have less severe disease after four months of therapy, compared to people who took a placebo (sugar pill).
  • Those who used apremilast were more likely to have smaller areas of their skin affected by psoriasis plaques and were less likely to have an affected scalp.
  • People using apremilast had improved symptoms, such as less itching.

This trial also showed that apremilast is safe. Researchers identified a few potential side effects, including headache, nausea, diarrhea, and cold symptoms.

Posted on January 12, 2022

A MyPsoriasisTeam Member

Otezla did nothing for my PsA and the side effects were dreadful. I'd rather take NSAIDs (which don't help psoriasis but helps the joint pain) and keep psoriasis rather than live my life with… read more

April 2, 2023
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
Ariel D. Teitel, M.D., M.B.A. is the clinical associate professor of medicine at the NYU Langone Medical Center in New York. Review provided by VeriMed Healthcare Network. Learn more about him here.
Maureen McNulty studied molecular genetics and English at Ohio State University. Learn more about her here.

Related Articles

A recent study found that nearly 1 in 3 people with psoriasis achieved clear or almost clear ski...

33% See Skin Clearance From At-Home Light Therapy

A recent study found that nearly 1 in 3 people with psoriasis achieved clear or almost clear ski...
This fall and winter, the Centers for Disease Control and Prevention (CDC) expects the number of ...

3 Layers of COVID-19 Protection: New Vaccines, Prevention Drug, and Tests

This fall and winter, the Centers for Disease Control and Prevention (CDC) expects the number of ...

Recent Articles

Certain underlying health conditions are more common in people with psoriatic arthritis (PsA) tha...

Comorbidities and Complications of Psoriatic Arthritis

Certain underlying health conditions are more common in people with psoriatic arthritis (PsA) tha...
Psoriatic arthritis (PsA) is a complex disease characterized by joint pain, tenderness, and swell...

8 Treatments for Psoriatic Arthritis: What’s Best for You?

Psoriatic arthritis (PsA) is a complex disease characterized by joint pain, tenderness, and swell...
Psoriatic arthritis (PsA) is a chronic inflammatory condition affecting the joints and skin that ...

6 Immunosuppressant Medication Types for Psoriatic Arthritis and How They Work

Psoriatic arthritis (PsA) is a chronic inflammatory condition affecting the joints and skin that ...
For many people, injectable medications are a good option for treating psoriatic arthritis (PsA)....

Psoriatic Arthritis Injections: Names, How They Work, and More

For many people, injectable medications are a good option for treating psoriatic arthritis (PsA)....
It’s not always easy to find the motivation to eat a balanced diet and be physically active when ...

Psoriatic Arthritis and Weight: Can Joint Inflammation Cause Weight Gain?

It’s not always easy to find the motivation to eat a balanced diet and be physically active when ...
About one-third of the 7.5 million people in America living with psoriasis also have psoriatic ar...

What Back Pain With Psoriatic Arthritis Feels Like

About one-third of the 7.5 million people in America living with psoriasis also have psoriatic ar...
Translation missing: pst.site_noun_short News

Thank you for subscribing!

Become a member to get even more: